NetForum uses cookies to ensure that we give you the best experience on our website. If you continue to use the site, we'll assume that you are happy to receive these cookies on the NetForum website. Read about our cookies.
NetForum Community
Learn. Share. Optimize.
Log in | Sign up now | Submit content | Contact
Vincent Vandecaveye
M.D., Ph.D.
Radiologist
   Member since: 02/16/11

Enterprise: University Hospitals Leuven
Leuven, Belgium

Institution Type: Academic Center

vincent.vandecaveye@uz.kuleuven.be
 


Rating:
Votes:
0
Views:
12787
Added:
Feb 16, 2011

Rate this:
Log in to vote
 

Clinical Specialty: Abdominal and Head and Neck radiology
 

Most recent Best rated Most viewed
Head-neck primary tumor visualization and staging
Patient with right-sided glottis cancer showed cystic metastatic adenopathy in right neck (level II). As this is an unusual presentation for glottic cancer, the patient was referred to MRI at University Hospitals Leuven.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Nov 05, 2013
Rating:
(1)
Views: 2789
Ingenia 3.0T Head-Neck with large coverage - Univ. Hosp. Leuven
This R4.1.2 Ingenia 3.0T ExamCard includes scans for large coverage (from skull base down to thoracic inlet) in short scan time. DWI and 4D THRIVE are included for functional as well soft tissue imaging.
MRIExamCard
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Nov 05, 2013
Rating:
(0)
Views: 1686
Ingenia 3.0T enhances head and neck imaging at Leuven
Ingenia’s high SNR and homogeneity are boosting the diagnostic quality of head and neck MRI exams at University Hospitals Leuven.
MRIBest Practice
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Nov 05, 2013
Rating:
(0)
Views: 4317
Nodal staging in recurrent thyroid cancer
After thyroidectomy 2 years ago for small papillary thyroid cancer, ultrasound revealed a nodule. The patient was then examined on Ingenia 3.0T at University Hospitals Leuven.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Nov 05, 2013
Rating:
(0)
Views: 906
Recurrent head and neck cancer
A patient with recurrent head/neck cancer underwent an MRI examination on Ingenia 3.0T at University Hospitals Leuven.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Nov 05, 2013
Rating:
(1)
Views: 1624
Leuven research is fine-tuning 3.0T DWIBS for whole body staging
Dr. Vandecaveye has been assessing the value of 3.0T DWIBS in staging of suspicious lesions according to the TNM method in a single scan. Working with an Achieva 3.0T TX with MultiTransmit technology, the Leuven team is achieving very promising results.
MRIBest Practice
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Sep 08, 2010
Rating:
(1)
Views: 2266
Lung tumor and metastatic lesion
A patient with lumbar pain and left radicular pain underwent whole body diffusion-weighted MRI on the Achieva 3.0T TX at University Hospital Leuven, Belgium.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Sep 08, 2010
Rating:
(0)
Views: 3835
Suspected neuro-endocrine tumor
A patient with suspected neuro-endocrine tumor underwent PET, CT and whole body diffusion-weighted MRI on the Achieva 3.0T TX at University Hospital Leuven, Belgium.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Sep 08, 2010
Rating:
(0)
Views: 1786
Recurrent cutaneous melanoma
A patient with recurrent cutaneous melanoma underwent FDG-PET, CT and whole body diffusion-weighted MRI on the Achieva 3.0T TX at University Hospital Leuven, Belgium.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Sep 08, 2010
Rating:
(0)
Views: 1886
Lymphoma treatment response
A patient with lymphoma underwent CT, PET and 3.0T whole body MR before and 2 weeks after start of therapy at University Hospital Leuven, Belgium.
MRICase Study
By: Vandecaveye, Vincent, M.D., Ph.D.
On: Sep 08, 2010
Rating:
(0)
Views: 1443

Clinical News
Best Practices
Case Studies
Publications and Abstracts
White Papers
Web seminars and Presentations
ExamCards
Protocols
Application Tips and FAQ
Training
Try an Application
Business News
Case Studies
White Papers
Web Seminars and Presentations
Utilization Services
Contributing Professionals
Contributing Institutions
Become a Contributor